Email me at SteveSlr *at* aol*dot*com (make the obvious substitutions between the asterisks; you don't have to capitalize an email address, I just included the capitals to make clear the logic -- it's my name without a space and without the vowels in "Sailer" that give so many people, especially irate commenters, trouble.) I always appreciate my readers' help, especially monetary. Here's how you can help: First: You can use PayPal (non-tax deductible) by going to the page on my old blog here. PayPal accepts most credit cards. Contributions can be either one-time only, monthly, or annual.

Our Random Forest model predicts a 66% probability of the OVER 41 points hitting with odds from Westgate in this matchup. The expected value is 30 with a 103 Diff. Check out all the betting info for the Jacksonville Jaguars vs Carolina Panthers on our matchup page. Our Random Forest model predicts a 79% probability of the Indianapolis Colts keeping it within the 5.5 points being offered at the Westgate. The expected value is 50 with a 303 Diff.

Researchers have developed a computer method using AI techniques that could lead to a deeper understanding of, and treatment for, Crohn's disease, a chronic gastrointestinal inflammation that affects up to 780,000 people in the US alone. The team from Rutgers University, which published the results of the study in the journal Genome Medicine, used artificial intelligence to examine genetic signatures of Crohn's in 111 people, including 64 people with a Crohn's disease diagnosis. Researchers then used an artificial intelligence method, known as AVA,Dx (Analysis of Variation for Association with Disease), to identify genes whose functions changed more in Crohn's patients than in healthy people. The researchers were able to highlight known Crohn's disease genes, as well as new potential Crohn's genes. AVA,Dx also identified 16 percent of Crohn's patients at 99 percent precision, and 58 percent of the patients with 82 percent precision in over 3,000 individuals from separately sequenced panels.

Drug discovery needed to change. The low-hanging fruit had been harvested, but the biopharma industry, in the words of Deep Genomics CEO Brendan Frey, is still shoving the tree until an apple falls. "Making drugs has traditionally been a gambling game. Big Pharma is throwing a stick into the tree and seeing what happens," Frey told FierceBiotech. "It's like the Big Pharma companies come into a casino, put a million-dollar coin into a slot machine and with some probability like 10% or something, they get a win."

Big data, unstructured or structured, fast or slow, in multiple contexts or one is a beast to manage. Big data is growing fast fueled by the democratization of data and the IoT environment. Often organizations simply control what they know they get results from and then store the rest for future leverage. In fact, most organizations use less than 20% of their data, leaving the remaining 80%, and the insights it contains, to be left outside to the operational and decision-making processes. Imagine if you used only 20% of any service you paid for every month and ignored the other 80%!

But Vallor – a leading American scholar of the ethics of data and artificial intelligence shortly to flit to Edinburgh University – reckons we should be concerned with military robots. Because of the people who may control them. Science fiction writers have fretted for decades about the moral philosophy of smart robots. What, at least in popular culture, we have not done so much is think about the ethics of dumb humans who will suddenly have control of vast amounts of artificial intelligence. That is where thinkers like Vallor come in.

The Machine Learning as a Service Market report provides an unbiased and detailed analysis of the on-going trends, opportunities/ high growth areas, market drivers, which would help stakeholders to device and align Machine Learning as a Service market strategies according to the current and future market The Machine Learning as a Service Market report covers the Global market and regional market analysis. The Machine Learning as a Service industry report examines, keep records and presents the worldwide market size of the important players in each region around the globe. Also, the report offers information of the leading market players in the Machine Learning as a Service market. Look insights of Global Machine Learning as a Service industry market research report at https://www.pioneerreports.com/report/519493 The overviews, SWOT analysis and strategies of each vendor in the Machine Learning as a Service market provide understanding about the market forces and how those can be exploited to create future opportunities.

Big data and machine learning have emerged as fundamental tools for companies and cities looking to unlock insights into people and places, enabled by the myriad connected devices that now permeate society. The likes of PredictHQ leverage data from global events to help companies like Uber and airlines forecast demand, while fellow San Francisco startup Streetlight Data aggregates mobile app data to help cities measure the flow of traffic. In a similar vein, Israeli startup Waycare has been setting out to help city planners make better-informed traffic-management decisions. It does so by tapping historical and real-time data inputs from connected cars, telematics, roadside cameras, fleet management platforms, public transit services, construction projects, and even weather forecasts to build a more complete picture of what's happening on a city's thoroughfares. Individually, these various data sets can do little to help municipalities make planning decisions, but the sum -- as the saying goes -- is far greater than its parts.

Decision Point AI are working with the Paisley YMCA, Scotland on a secure application that standardises both the SHANARRI social framework processes and its data. SHANARRI is an acronym for the eight wellbeing indicators in the Curriculum for Excellence (CfE) in Health and Wellbeing. It stands for Safe, Healthy, Achieving, Nurtured, Active, Respected, Responsible, Included. The indicators are used to structure the information recorded about a child or young person and to monitor their progress across social services. Since starting Decision Point AI, we have had to work hard to demystify AI and focus on real world problems with potential clients.

AI Medical Service, a Tokyo-based company developing AI-based software to help detect gastric cancer, announced today that it has raised a $42.9 million Series B. Investors include Globis Capital Partners, World Innovation Lab and Sony Innovation Fund by IGV. The funding will be used for clinical trials of its software, which looks for signs of cancer in real-time during endoscopies, product development and overseas expansion. This brings AI Medical Service's total funding so far to $57 million, including a previous round of $9 million from the Incubate Fund in August 2018. Founded in 2017, the company's software focuses on signs of cancer in gastrointestinal organs, including the esophagus, stomach and intestines, with the goal of reducing the amount of hours doctors and other health professionals need to spend going over scans. AI Medical Service is currently collaborating with 80 medical institutions on joint research for regulatory approval of its products.